Vioquest Pharmaceuticals, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * LENZ BRIAN	2. Issuer Name and Ticker or Trading Symbol VioQuest Pharmaceuticals, Inc. [ VQPH ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                      _____ 10% Owner __ X __ Officer (give title below)      _____ Other (specify below) CFO and Treasurer
(Last)          (First)          (Middle) 180 MT. AIRY ROAD, SUITE 102	3. Date of Earliest Transaction (MM/DD/YYYY) 6/13/2008
(Street) BASKING RIDGE, NJ 07920 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY) 6/17/2008	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								1500   (1)	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant	$4.00   (1)							6/29/2007	6/29/2012	Common Stock, $.001 par value	328   (1)		328   (1)	D
Warrant	$1.00   (1)							4/9/2008	4/9/2013	Common Stock	8333   (1)		8333   (1)	D
Series B Convertible Preferred Stock	$3.80   (1)							3/14/2008	(8)	Series A Convertible Preferred Stock	5		.285	D
Series A Convertible Preferred Stock	$0.60   (1)							4/9/2008	(8)	Common Stock	8333   (1)		10	D
Stock Options	$16.70   (1)	6/13/2008		D  (2)			1500   (1)	(2)	10/6/2013	Common Stock	1500   (1)	$0	0	D
Stock Options	$0.54	6/13/2008		A  (2)		1500		(2)	10/6/2013	Common Stock	1500	$0	1500	D
Stock Options	$14.00   (1)	6/13/2008		D  (3)			2500   (1)	(3)	4/19/2014	Common Stock	2500   (1)	$0	0	D
Stock Options	$0.54	6/13/2008		A  (3)		2500		(3)	4/19/2014	Common Stock	2500	$0	2500	D
Stock Options	$10.80   (1)	6/13/2008		D  (4)			6000   (1)	(4)	1/24/2015	Common Stock	6000   (1)	$0	0	D
Stock Options	$0.54	6/13/2008		A  (4)		6000		(4)	1/24/2015	Common Stock	6000	$0	6000	D
Stock Options	$10.30   (1)	6/13/2008		D  (5)			10000   (1)	(5)	11/29/2015	Common Stock	10000   (1)	$0	0	D
Stock Options	$0.54	6/13/2008		A  (5)		10000		(5)	11/29/2015	Common Stock	10000	$0	10000	D
Stock Options	$8.50   (1)	6/13/2008		D  (6)			10000   (1)	(6)	3/31/2016	Common Stock	10000   (1)	$0	0	D
Stock Options	$0.54	6/13/2008		A  (6)		10000		(6)	3/31/2016	Common Stock	10000	$0	10000	D
Stock Options	$5.50   (1)	6/13/2008		D  (7)			10000   (1)	(7)	5/11/2007	Common Stock	10000   (1)	$0	0	D
Stock Options	$0.54	6/13/2008		A  (7)		10000		(7)	5/11/2017	Common Stock	10000	$0	10000	D
Stock Options	$1.20   (1)	6/13/2008		D  (9)			80000   (1) (11)	(9)	2/28/2018	Common Stock	80000   (1) (11)	$0	0	D
Stock Options	$0.54	6/13/2008		A  (9)		80000   (11)		(9)	2/28/2018	Common Stock	80000   (11)	$0	80000   (11)	D
Stock Options	$0.54	6/13/2008		A		80000		(10)	6/13/2018	Common Stock	80000	$0	80000	D

Explanation of Responses:
( 1)	Adjusted to reflect a 1-for-10 reverse stock split effective on 4/25/2008.
( 2)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/6/2003 and is fully vested.
( 3)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 4/19/2004 and is fully vested.
( 4)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 1/24/2005 and is fully vested.
( 5)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 11/29/2005 and provides for vesting in three annual installments beginning on 11/29/06.
( 6)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 3/31/2006 and provides for vesting in three annual installments beginning on 3/31/07.
( 7)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 5/11/2007 and provides for vesting in three annual installments beginning on 5/11/2008.
( 8)	No expiration date.
( 9)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 2/28/2008 and provides for vesting in three annual installments beginning on 2/28/09 and is subject to acceleration under certain circumstances.
( 10)	Option vests in three annual installments beginning on 6/13/08.
( 11)	Form amended to correct typographical error.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
LENZ BRIAN 180 MT. AIRY ROAD, SUITE 102 BASKING RIDGE, NJ 07920			CFO and Treasurer

Signatures
/s/ Brian Lenz		7/2/2008
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.